Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-26 · accession 0001822629-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-27 | 2024-11-26 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale+OE | $57.99 | -33.5K | 370.4K | -8% | -$1.94M |
| D | 2024-11-27 | 2024-11-26 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | +30.0K | 403.9K | +8% | +$870.0K |
| D | 2024-11-27 | 2024-11-26 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | -30.0K | 138.0K | -18% | -$870.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | S | D | 30,000 | $57.95 | 373,859 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2024-11-26 | M | A | 30,000 | $29.00 | 403,859 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-26 | S | D | 3,481 | $58.30 | 370,378 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price. |
| 4 | Derivative | Stock Option (right to buy) | 2024-11-26 | M | D | 30,000 | $29.00 | 138,027 | D | $29.00 · — to 2030-09-08 | 30,000 Common Stock | (F3) 25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024. |